The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)

Organization
NIH
Type
NIH
Application Due Date
03-03-2020
Number
PAR-18-830
Comments
Application Due Date(s): March 3, 2020, November 7, 2020, June 3, 2021, by 5:00 PM local time of applicant organization.
Brief Description

Funding Opportunity Purpose

The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA.  Evidence is accumulating that RNA modifications regulate the function of both coding and noncoding RNAs, suggesting that these modifications are involved in both development, and in health and disease.  Yet the extent and types of these RNA modifications as well as their roles in particular biological processes remain either poorly understood or not known.  The goal of the FOA is to promote research into the role of RNA chemical modifications in the initiation and progression of various developmental processes and disease states and conditions relevant to the scientific mission of the participating ICs.